Only 2 weeks until the  #ATS2024 congress in San Diego! We're eagerly counting down the days until we can connect with you at booth #3331 to introduce our innovation in early Lung Cancer diagnosis through #eyonis ™, our cutting-edge #AI / #ML tech-based CADe/CADx software.

Meet us at #ASCO2024 ! Visit booth #15142, McCormick Place, Chicago, June 1-3. Discover how Median's AI technologies revolutionize medical imaging for cancer diagnosis, treatment, and monitoring. Excited to connect! #medicalimaging #clinicaltrials #AItechforhealth .

‼ Au sommaire de @tribuca n°1245 ‼️🗞️
▶️Viva Technology en approche, le #06 dans les starting-blocks
▶️Face aux cyber-attaques Sophia Antipolis contre-attaque
▶️Première salve d'ouvertures sur #iconic #Nice06
▶️Focus : Median Technologies, Vueling Airlines, ExactCure …
tribuca.net/actualites_128…

#Median Technologies reports full-year 2023 financial results and provides first quarter 2024 financial information
Our press release 👉👉mediantechnologies.com/investors/pres… #AIforbetterhealth

Join Median Technologies and #PASRELImagerie at #Meet2Win , Partnering Convention in cancer innovation, to hear the workshop 3 !
Join the community on May 16 & 17 in Bordeaux !
➡️ meet2win.fr
An event MATWIN Unicancer

Our clinical trial imaging team is enjoying Clinical Trials in Oncology West Coast and looking forward to another day of networking and conversations on all things imaging for oncology research.
Stop by booth 16A to connect at hashtag#CTOWC24!

We're thrilled to announce that the #Median and #eyonis ™ team will be exhibiting at  #ATS2024 , and we can't wait to connect with you there! Find us at booth #3331, where we'll be showcasing the latest advancements in eyonis™, our suite of #AI / #ML tech-based CADe/CADx Software.

Today, World Liver Day highlights the global impact of liver disease. At #Median and with #eyonis ™ AI/ML Software, we're dedicated to supporting healthcare professionals by developing innovative solutions to detect liver cancer early, contributing to improved outcomes worldwide

🔬 Meet with us live on the West Coast later this month! 🔬
Discover how our imaging expertise and operational excellence provide best-in-class central imaging services for oncology clinical trials. Visit us at booth #16A !
#clinicaltrials #medicalimaging #oncology

Our latest podcast episode is available here: mediantechnologies.com/insights/artic…
Join us in our insightful conversation with Dr. Antoine Iannessi, Head of Medical Affairs at Median, where we delve into the impact of variability in imaging interpretation on oncology clinical trial results.

Exciting news! AACR 2024 is just around the corner, and our US team can't wait to showcase our cutting-edge imaging solutions for #oncologytrials and the latest in AI-powered imaging intelligence. See you at AACR 2024!
#AACR24 #OncologyImaging #AIinHealthcare #CancerResearch

Since 1938, April is National Cancer Control Month. #eyonis ™ aids early cancer diagnosis & survival rates by supporting Radiologists, Oncologists, Pulmonologists, & Hepatologists with #AI / #ML Software for Lung & Liver cancer detection and characterization.

In the last decade, lung cancer screening recommendations expanded, now reaching 19 million Americans, up from 6 million. #Median Technologies - eyonis™ aids this shift with #AI / #ML Software as a Medical Device, assisting in interpreting lung scans for early nodule detection.

Dive into the future of oncology clinical trials with our CEO and Founder, fredrik brag! In collaboration with Citeline, our podcast explores the transformative power of #AI in oncology clinical trials.
🎧✨Listen to the #MedianPodcast here: mediantechnologies.com/insights/artic…

Happy #IWD2024 ! Today we want to reinforce our commitment with equality. In accordance with the French legal obligation to report a #GenderEquality index every year, we are proud of our efforts and are glad to announce that for 2023, we scored 88/100. internationalwomensday.com

Our iCRO team is thrilled to announce the successful completion of an inspection by the U.S. FDA as part of their Bioresearch Monitoring Program (BIMO). This program ensures the highest quality and integrity of data submitted to the #FDA in support of new medicines.

#IO360 is a wrap! We enjoyed the conversations regarding how together we can advance the field of immuno-oncology with Median iCRO expertise and AI-powered innovation for oncology trials. Thank you to Dr. Antoine Iannessi, for your inspiring presentation on tumor growth kinetics.

Exciting times at #IO360 ! Join us today and tomorrow at booth #40 to engage in insightful discussions with Median’s iCRO team about the pivotal role of imaging in immuno-oncology clinical trials. 💡
#IO360 nyc #clinicaltrials #Oncology

#ECR2024 : Feb. 29, 2024, at 12:50 CET Anne Chibois, Pr. Philippe Grenier, and Pr. Olivier Lucidarme will unveil the latest independent verification study results LCS and preliminary HCC diagnosis for eyonis™ our unique end-to-end AI/ML tech-based SaMD suite.

#ECR2024 : On Feb. 28 at 12:30 CET, Anne Chibois and Benoit Huet, will present on “eyonis™ LCS: Revealing Independent Verification Results & Advancements in Clinical Validation Studies”. Join us at the AI Theatre and at our booth #AI -17 both at the Expo X1, AI-area.